Medicines and Trade Name Registration




NEW ZEALAND GAZETTE, No. 140 — 20 NOVEMBER 2014

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Clonidine Transdermal System, USP
Clonidine 7.56mg equivalent to 0.3mg/24hr
Transdermal patch
Mylan New Zealand Limited
Mylan Technologies, Vermont, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Gacet
Paracetamol 125mg
Suppository
AFT Pharmaceuticals Limited
Bliss GVS Pharma Limited, Maharashtra, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Invokana
Canagliflozin hemihydrate 102mg equivalent to Canagliflozin 100mg
Film coated tablet
Janssen-Cilag (New Zealand) Limited
Janssen Ortho LLC, Gurabo, Puerto Rico

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Invokana
Canagliflozin hemihydrate 306mg equivalent to Canagliflozin 300mg
Film coated tablet
Janssen-Cilag (New Zealand) Limited
Janssen Ortho LLC, Gurabo, Puerto Rico

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Lice Clear
Permethrin 1%w/w
Scalp lotion
AFT Pharmaceuticals Limited
Hoe Pharmaceuticals Sdn Bhd, Selangor, Malaysia

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Opsumit
Macitentan 10mg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Patheon Italia SpA, Milan, Italy

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Travopt
Travoprost 0.04mg/mL
Eye drops, solution
Mylan New Zealand Limited
Wintac Limited, Karnataka, India

Dated this 13th day of November 2014.

STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2014-go7063

Notice of Application to Register a Trade Name Product (Notice No. MPI 412)

Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Ubrolexin Intramammary Suspension
Reference: A11098
Active Ingredients and Concentrations:
200mg Cefalexin (as monohydrate)
100,000IU Kanamycin (as monosulphate)
Formulation Type: Oily Suspension
General Use Claim:

145



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 140





✨ LLM interpretation of page content

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
13 November 2014
Medicines, Consent, Distribution, Medsafe, Ministry of Health
  • Stewart Jessamine, Group Manager, Medsafe, Ministry of Health

🌾 Notice of Application to Register a Trade Name Product

🌾 Primary Industries & Resources
Trade Name Registration, Agricultural Compounds, Veterinary Medicines, MPI
  • Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries